Rethinking approaches to analysis of global randomised controlled trials Post date 20 June 2025 ← Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug → Ticagrelor doubts: inaccuracies uncovered in key studies for AstraZeneca’s billion dollar drug